We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current IPH market cap is 176.68M. The company's latest EPS is EUR -0.7186 and P/E is -3.03.
Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
Total Revenue | 93.95M | 85.81M | 71.32M | 26.5M | 57.89M |
Operating Income | 5.21M | -27.05M | -62.08M | -54.98M | -57.53M |
Net Income | 3.05M | -20.76M | -63.98M | -52.81M | -58.1M |
Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
Total Assets | 451.22M | 401.36M | 307.42M | 267.5M | 207.86M |
Total Liabilities | 283.98M | 183.95M | 151.45M | 160.06M | 153.71M |
Total Equity | 167.24M | 217.42M | 155.98M | 107.44M | 54.15M |
Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
Operating | -32.53M | 34.92M | -51.77M | -58.46M | -19.15M |
Investing | 24.28M | -62.12M | -13.37M | -917k | 1.88M |
Financing | 61.22M | 77.77M | -1.18M | 26.82M | -1.83M |
Market Cap | 176.68M |
Price to Earnings Ratio | -3.03 |
Price to Sales Ratio | 3.05 |
Price to Cash Ratio | 2.09 |
Price to Book Ratio | 3.26 |
Dividend Yield | - |
Shares Outstanding | 80.86M |
Average Volume (1 week) | 37.25k |
Average Volume (1 Month) | 67.48k |
52 Week Change | -17.73% |
52 Week High | 3.345 |
52 Week Low | 2.11 |
Spread (Intraday) | 0.04 (1.82%) |
Company Name | Innate Pharma |
Address |
117 avenue de luminy marseille, bouches-du-rhone 13009 |
Website | https://www.innate-pharma.com |
Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions